HUMAN SAFETY AND PHARMACOLOGY OF FTY 720
R. Brunkhorst(Klinikum Region Hannover), Robert Schmouder(Novartis (United States)), L Brookman(Novartis (Switzerland)), P Lücker(Hochschule Hannover), Neumayer Hh(Hochschule Hannover), Tina Mayer(Hochschule Hannover), Klemens Budde(Charité - Universitätsmedizin Berlin)
Cited by 11
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|623
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2010|574